VoyageFor Vets
Dispatch

Veterinary Clinical Reference

Look up any drug or condition.

Evergreen, evidence-based hubs on the drugs, conditions, and species you manage — continuously updated and cited at every claim.

/
107 evergreen hubsCited at every claimContinuously updatedFree for verified vets
All (107)Pain & Osteoarthritis (8)Dermatology & Allergy (7)Cardiology (4)Neurology & Epilepsy (7)Endocrinology (3)GI & Appetite (5)Infectious Disease (3)Nephrology & Urology (1)Ophthalmology (5)Behavior (8)Immunology & Oncology (3)Toxicology & Emergency (10)Exotic & Zoological (43)
All species (3)Feline (2)Canine (1)
CanineJun 7, 2026

Trilostane (Vetoryl) for Canine Hyperadrenocorticism: Evidence and Monitoring

Trilostane (Vetoryl) inhibits 3β-HSD for canine hyperadrenocorticism, resolving PU/PD in 70% and skin changes in 62% of dogs. Emerging evidence favours pre-trilostane cortisol over the ACTH stimulation test for monitoring clinical control.

Read →

Voyage surfaces cited veterinary evidence to inform your clinical judgment — never to replace it. Always confirm dosing and treatment against current formularies.

Built for pets. Not repurposed from humans.

Built by Voyage